Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3752_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
24 Мб
Скачать
181
within the shaft body and proved to be helpful in a subset of patients with unspecifi c symptoms after bypass surgery.
With later generations of multidetector CT systems and improvements in spatial and temporal resolution stenosis detection in more diffi cult situations such as the bypass anas­tomosis region or visualization of arterial grafts surrounded by metal clips was enhanced. Currently, arterial grafts and the anastomosis region of venous and arterial grafts can be analyzed with increased diagnostic yield [ 1119 ] (Figs. 10.1 and 10.2 ). Even the analysis of native vessel disease progres- sion became more accurate with multidetector CT scanners [ 15 ] (Fig. 10.3 ). Regarding the exclusion of high-grade ste- noses, the negative predictive value was 100 % for bypass grafts and 96–98 % for the native coronary arteries (grafted or nongrafted). Only 9 % of the native coronary arteries were unevaluable due to severe calcifi cations or motion artifacts.
A meta-analysis by Hamon et al. comprised studies using 16- and 64-slice MDCT published up to May 2007 [ 11 ]. A total of 15 studies were included, six of which used 64-slice CT [ 1217 ]. Table 10.1 gives an overview of the diagnostic performance of 64-slice MDCT in a total of 355 patients and 976 bypass grafts [ 11 ]. Between 87 and 100 % of the grafts were fully assessable regarding the detection / exclusion of angiographically signifi cant stenoses. In particular, a high negative predictive value was obtained in the studies, indicating the ability to reliably rule out high-grade stenoses or obstruction of the bypass grafts using 64-slice MDCT. More recent studies have confi rmed a negative
predictive value for ruling out high-grade bypass graft stenoses ranging between 96 and 99 % [ 1820 ]. However, depending on the anatomy, the distal anastomosis can still be challeng­ing to examine, and the degree of stenosis tends to be overes­timated [ 18 ]. The native coronary circulation can be assessed despite previous bypass surgery [ 1921 ] (Fig. 10.4 ), how- ever, as in a population with no previous bypass surgery, heavy coronary calcifi cation or a small native vessel diame­ter can render the CT analysis diffi cult. Sensitivities for the detection of signifi cant lesions range between 86–95 % for distal runoffs and 86–97 % for non grafted arteries.
A recent publication demonstrated the prognostic value of CCTA in coronary bypass patients [ 22 ]. Both bypass grafts and native coronary arteries were analyzed regarding the number of unprotected coronary territories (UCT). The inci­dence of myocardial infarction as well as the risk of death increased signifi cantly with higher numbers of UCT. Hence, CCTA not only provides morphologic information on the coronary anatomy but also prognostic data.
Imaging Protocols
Most experts agree that consequential betablockade should be undertaken with the aim of reaching heart rates ≤ 60–65 bpm, which improves image quality due to less motion artifacts and may reduce radiation exposure. Although most recent scanner generations are less susceptible to motion artifacts, practical experience dictates that this approach yields superior visibility of coronary artery segments. The administration of oral or intravenous nitrates for vasodilata­tion immediately prior to the scan is recommended. A tempo­ral window of 60 % of the RR-interval appears to be best suited [ 23 ]. Caudo-cranial scan direction seems to be supe- rior in terms of image quality and radiation exposure [ 24 ]. The latest development in CT scanners led to a remarkable decrease in radiation exposure (prospective ECG-gating, reduced tube voltage, tube current modulation, higher acqui­sition speed) which is on average lower than in ICA.
Specifi c scanning protocols with the various scanners are detailed elsewhere in this book.
Conclusions to Bypass Grafts
CCTA is increasingly used as a modality for the non-invasive assessment of bypass graft patency and stenoses. As compared to ICA, a small proportion of grafts remains unassessable due to artifacts or anatomic complexity. However, this proportion has decreased with improvements in scanner technology. Bypass grafts as well as native coronary arteries can be evaluated with high diagnostic accuracy. ICA remains gold standard for defi ning coronary
Fig. 10.2 64-row MDCT 3-dimensional image reconstruction shows a patent left internal mammary graft with two anostomoses to the fi rst diagonal branch and left anterior descending coronary artery itself, respectively
10 Coronary CT Angiography After Revascularization
https://t.me/medicina_free
182
bypass anatomy, but especially in patients with non-specifi c complaints, CCTA is an excellent alternative and provides a nice roadmap to see the origin locations and number of
patent grafts in those patients without prior recent angiogra­phy, including use of right and left internal mammaries non-invasively.
aba
b
Fig. 10.3 64-row MDCT 3-dimensional image reconstruction ( a ) shows a patent left internal mammary graft to the left anterior descending coronary artery and the corresponding selective angiogram. Distal to the anastomosis, the left anterior descending coronary artery is occluded; see corresponding invasive angiographc image ( b )
Table 10.1 Results of 64-slice MDCT examination of 976 bypass grafts as documented in a meta-analysis by Hamon et al.
a
Sensitivity (%) Specifi city (%)
Positive predictive value (%)
Negative predictive value (%)
Positive likelihood ratio
Negative likelihood ratio
98.1 (96.0,99.3) 96.9 (95.3,98.1) 94.1 (91.0,96.3) 99.1 (98.0,99.7) 24.7 (12.5,47.7) 0.03 (0.01,0.06)
Numbers in parentheses = 95 % CI
a
Data from Hamon et al. [ 11 ]
J. Eckert et al.
https://t.me/medicina_free
183
Coronary Stents
Background
The majority of percutaneous coronary angioplasties are performed with placement of a stent in the vessel wall [ 25 ]. Most stents are made of stainless steel or cobalt-chromium, which can both be challenging to visualize using CCTA due to motion artifacts and “blooming”. Usual stent diameters range between 2.5 and 4 mm. The widespread use of drug eluting stents has signifi cantly reduced the risk of in-stent restenosis [ 26 ]. Vessel size, stented length, co morbidities, lesion morphology, and previous bypass surgery are predic­tors of higher rates of restenosis [ 26 ].
Depending on materials and size, stents can have a widely different appearance in CCTA. A closed cell design with a higher metal-to-surface ratio makes it more diffi cult to visualize the stent lumen than an open cell design. New generations of bioresorbable scaffolds
(BRS), on the other hand, made of magnesium or polylactid polymer, are free of metal and may be visual­ized only by radioopaque markers at the extreme ends of the scaffold.
Non-invasive CT Examination
Early EBCT-studies used time-density curve analysis in a region of interest distal to the stent comparing it to the pattern in the aorta [ 2729 ]. This led to a reliable detection of com- plete occlusions whereas high-grade and subtotal stenoses were frequently missed because of the fact that contrast fl ow may pass subtotal stenoses and collateral vessels may fi ll the vessel lumen retrogradely.
Apart from motion artifacts, in vitro studies revealed fur­ther stent-related problems –– in CT imaging such as enhancement of the stent struts (“blooming”), apparent reduction of the stent lumen, attenuation of contrast values
ab
Fig. 10.4 Patent left internal mammary graft to the left anterior descending coronary artery with normal runoff ( a ). Patent single vein graft to the right coronary artery with normal runoff ( b ). Bypass grafts as well as the native coronary arteries can be evaluated with good image quality
10 Coronary CT Angiography After Revascularization
https://t.me/medicina_free
184
Fig. 10.5 Ultra-high resolution images of a coronary stent using 64-row MDCT. The two left panel pictures show the stent mounted on a vessel model placed in a phantom with realistic attenuation values. The short arrow marks an artifi cial 30 % in-stent restenosis (produced
within the stented vessel model), the longer arrow a 50 % restenosis in the same setting. The right panel shows a three-dimensional reconstruction of the stent
ab
Fig. 10.6 Intermediate in-stent-stenosis of a 3.25 × 16 mm bare-metal-stent in the proximal left anterior descending artery ( a ). Corresponding invasive coronary angiogram of the left coronary artery ( b )
J. Eckert et al.
https://t.me/medicina_free
185
inside the lumen and beamlike artifacts adjacent to the stent [ 3033 ] (Fig. 10.5 ). Improvements in CT technology like multi slice and dual-source scanners in recent years have increased the accuracy of detection of in-stent stenoses (Fig. 10.6 ). Nevertheless, stent artifacts are still problematic, and they vary between different types of stents [ 34 ]. Several studies have evaluated the accuracy of multislice CCTA in diagnosing in-stent stenoses versus ICA (gold-standard) [ 3540 ], partly combined with IVUS [ 38 ] or OCT [ 39 ]. Taking all segments into account, sensitivity was 50–100 %, specifi city 57–98 %, and negative predictive value (NPV) 96–100 %. Looking only at the assessable stents (predomi­nantly stents > 3.0 mm), sensitivity was 86–100 %, specifi c­ity 93–97 %, and NPV 98–100 %.
Besides patient-related aspects that impede image quality, in particular heart rate, vessel calcifi cations, motion artifacts, and obesity, stent diameter has been identifi ed as the most important stent-related factor. Stent diameters of 3.0 mm or more appear to have a signifi cantly higher diagnostic accu­racy on CCTA than smaller stents [ 38 , 40 ] (Fig. 10.7 ). A good correlation between CCTA and IVUS can be observed in the analysis of left main coronary artery stents [ 41 ]. The type of stent plays an essential role. A strut thickness of less than 100 μm is associated with less artifacts und thus improves diagnostic accuracy [ 38 ]. Due to the artifacts men- tioned above, CCTA tends to underestimate lumen area which may result in false positive fi ndings. On the other hand, stent occlusions or high-grade in-stent stenoses can be ruled out with confi dence (NPV 98–100 %). In 2010, a meta­analysis combined 14 studies assessing diagnostic accuracy of CCTA versus ICA [ 42 ]. In total, 89 % of all stents were assessable. Sensitivity for assessable stents was 90 %, speci­fi city 91 %.
Rief et al. showed improved diagnostic precision in com­bining CCTA with myocardial CT perfusion (CTP) [ 43 ]. CTP can add functional information concerning an in-stent stenosis and the need for revascularization (93 % sensitiv­ity). Fixed perfusion defi cits due to previous myocardial infarctions result, however, in a sensitivity of 65 % and PPV of only 33 % for CTP alone.
Recent bioresorbable stents (BRS) are hardly visible in CCTA and, unlike metal stents, do not generate artifacts. So far, comparative studies with other DES concerning diagnostic yield exist only in vitro [ 34 ]. Onuma et al. demonstrated the feasibility of CCTA and fractional fl ow reserve (FFR) in patients after implantation of an ABSORB BRS [ 44 ].
Imaging Protocols
Over the last decade there has been a dramatic reduction in radiation exposure with CCTA due to improvements in CT
scanner technology and image reconstruction, e.g., iterative reconstruction [ 45 , 46 ]. Image quality has improved due to the use of sharp, high-resolution kernels [ 47 , 48 ]. Most patients can be scanned with prospective ECG-triggering, resulting in a signifi cantly lower radiation exposure compared to the retrospective spiral mode. Xia et al. even examined patients after stent implantation with high-pitch spiral mode [ 49 ]. Diagnostic accuracy was equal to low-pitch spiral mode and sequential mode, effective dose was in the range of
1.0 mSv. Preparations for CCTA are the same for stent imaging as
for other CCTA indications and are described elsewhere in the book.
Fig. 10.7 Patent drug-eluting stent (3.0 × 18 mm) in the proximal left anterior descending artery
10 Coronary CT Angiography After Revascularization
https://t.me/medicina_free
186
Conclusion
Using new dual-source CT systems, coronary stents can be visualized with high diagnostic accuracy. In stents with diameters of 3.0 mm or more, in-stent stenoses can be ruled out with reasonably high certainty. Importantly, strut thickness of the stents has an impact on image qual­ity. Stents with a small strut thickness are better assess­able by CCTA than those with thicker struts. A new quality has been introduced by bioresorbable stents, whose materials are partly not visible in CCTA. Such stents can only be identifi ed by distinct radio-opaque markers at the extreme ends of the stent. ICA remains the gold-standard for the diagnosis of in-stent stenoses. For individual patients with prior implantation of relatively large coronary stents (3 mm), CCTA may offer an attractive alternative.
References
1. Riley RF, Don CW, Powell W, Maynard C, Dean LS. Trends in coronary revascularization in the United States from 2001 to 2009. Circ Cardiovasc Qual Outcomes. 2011;4:193–7.
2. Goldman S, Zadina K, Moritz T, VA Cooperative Study Group #207/297/364, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass sur­gery: results from a Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44:2149–56.
3. Schwartz L, Kip KE, Frye RL, Alderman EL, Schaff HV, Detre KM, Bypass Angioplasty Revascularization Investigation. Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 2002;106:2652–8.
4. Lytle BW, Loop FD, Cosgrove DM, Ratliff NB, Easley K, Taylor PC. Long-term (5 to 12 years) serial studies of internal mammary artery and saphenous vein coronary bypass grafts. J Thorac Cardiovasc Surg. 1985;89:248–58.
5. Shi Y, O’Brien Jr JE, Mannion JD, Morrison RC, Chung W, Fard A, Zalewski A. Remodeling of autologous saphenous vein grafts. The role of perivascular myofi broblasts. Circulation. 1997;95: 2684–93.
6. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616–26.
7. Berger A, MacCarthy PA, Siebert U, Carlier S, Wijns W, Heyndrickx G, Bartunek J, Vanermen H, De Bruyne B. Long-term patency of internal mammary artery bypass grafts. Relationship with preoperative severity of the native coronary artery stenosis. Circulation. 2004;110(suppl II):II-36–40.
8. Brundage BH, Lipton MJ, Herfkens RJ, Berninger WH, Redington RW, Chatterjee K, Carlsson E. Detection of patent coronary bypass grafts by computed tomography. A preliminary report. Circulation. 1980;61:826–31.
9. Daniel WG, Dohring W, Stender HS, Lichtlen PR. Value and limita­tions of computed tomography in assessing aortocoronary bypass graft patency. Circulation. 1983;67:983–7.
10. Achenbach S, Moshage W, Ropers D, Nossen J, Bachmann K. Noninvasive, three-dimensional visualization of coronary artery
bypass grafts by electron beam tomography. Am J Cardiol. 1997;79:856–61.
11. Hamon M, Lepage O, Malagutti P, et al. Diagnostic performance of 16- and 64-section spiral CT for coronary artery bypass graft assessment: meta-analysis. Radiology. 2008;247:679–86.
12. Malagutti P, Nieman K, Meijboom WB, et al. Use of 64-slice CT in symptomatic patients after coronary bypass surgery: evaluation of grafts and coronary arteries. Eur Heart J. 2007;28:1879–85.
13. Pache G, Saueressig U, Frydrychowicz A, et al. Initial experience with 64-slice cardiac CT: non-invasive visualization of coronary artery bypass grafts. Eur Heart J. 2006;27:976–80.
14. Dikkers R, Willems TP, Tio RA, Anthonio RL, Zijlstra F, Oudkerk M. The benefi t of 64-MDCT prior to invasive coronary angiography in symptomatic post-CABG patients. Int J Cardiovasc Imaging. 2006;23:369–77.
15. Ropers D, Pohle FK, Kuettner A, et al. Diagnostic accuracy of non­invasive coronary angiography in patients after bypass surgery using 64-slice spiral computed tomography with 330-ms gantry rotation. Circulation. 2006;114:2334–41.
16. Meyer TS, Martinoff S, Hadamitzky M, et al. Improved non­invasive assessment of coronary artery bypass grafts with 64-slice computed tomographic angiography in an unselected patient population. J Am Coll Cardiol. 2007;49:946–50.
17. Jabara R, Chronos N, Klein L, et al. Comparison of multidetector 64-slice computed tomographic angiography to coronary angiography to assess the patency of coronary artery bypass grafts. Am J Cardiol. 2007;99:1529–34.
18. Feuchtner GM, Schachner T, Bonatti J, et al. Diagnostic perfor­mance of 64-slice computed tomography in evaluation of coronary artery bypass grafts. AJR Am J Roentgenol. 2007;189:574–80.
19. Nazeri I, Shahabi P, Tehrai M, Sharif-Kashani B, Nazeri A. Assessment of patients after coronary artery bypass grafting using 64-slice computed tomography. Am J Cardiol. 2009;103: 667–73.
20. de Graaf FR, van Velzen JE, Witkowska AJ, et al. Diagnostic per­formance of 320-slice multidetector computed tomography coro­nary angiography in patients after coronary artery bypass grafting. Eur Radiol. 2011;21:2285–96.
21. Weustink AC, Nieman K, Pugliese F, et al. Diagnostic accuracy of computed tomography angiography in patients after bypass grafting: comparison with invasive coronary angiography. JACC Cardiovasc Imaging. 2009;2:816–24.
22. Mushtaq S, Andreini D, Pontone G, et al. Prognostic value of coro­nary CTA in coronary bypass patients: a long-term follow-up study. JACC Cardiovasc Imaging. 2014;7:580–9.
23. Desbiolles L, Leschka S, Plass A, et al. Evaluation of temporal win­dows for coronary artery bypass graft imaging with 64-slice CT. Eur Radiol. 2007;17:2819–28.
24. Lee SK, Jung JI, Ko JM, Lee HG. Image quality and radiation expo­sure of coronary CT angiography in patients after coronary artery bypass graft surgery: infl uence of imaging direction with 64-slice dual-source CT. J Cardiovasc Comput Tomogr. 2014;8:124–30.
25. Trikalinos TA, Alsheikh-Ali AA, Tatsioni A, Nallamothu BK, Kent DM. Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta­analysis. Lancet. 2009;373:911–8.
26. Cassese S, Byrne RA, Tada T, et al. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveil­lance angiography. Heart. 2014;100:153–9.
27. Schmermund A, Haude M, Baumgart D, Görge G, Grönemeyer D, Seibel R, Sehnert C, Erbel R. Non-invasive assessment of coronary Palmaz-Schatz stents with contrast enhanced electron beam computed tomography. Eur Heart J. 1996;17:1546–53.
28. Möhlenkamp S, Pump H, Baumgart D, Haude M, Gronemeyer DH, Seibel RM, Schwartz RS, Erbel R. Minimally invasive evaluation of coronary stents with electron beam computed tomography: In
J. Eckert et al.
https://t.me/medicina_free
187
vivo and in vitro experience. Catheter Cardiovasc Interv. 1999;48:39–47.
29. Pump H, Möhlenkamp S, Sehnert CA, Schimpf SS, Schmidt A, Erbel R, Gronemeyer DH, Seibel RM. Coronary arterial stent patency: assessment with electron-beam CT. Radiology. 2000;214:447–52.
30. Maintz D, Juergens KU, Wichter T, Grude M, Heindel W, Fischbach R. Imaging of coronary artery stents using multislice computed tomography: in vitro evaluation. Eur Radiol. 2003;13:830–5.
31. Mahnken AH, Buecker A, Wildberger JE, Ruebben A, Stanzel S, Vogt F, Günther RW, Blindt R. Coronary artery stents in multislice computed tomography: in vitro artifact evaluation. Invest Radiol. 2004;39:27–33.
32. Schlosser T, Scheuermann T, Ulzheimer S, et al. In-vitro evaluation of coronary stents and 64-detector-row computed tomography using a newly developed model of coronary artery stenosis. Acta Radiol. 2008;49:56–64.
33. Schlosser T, Scheuermann T, Ulzheimer S, et al. In vitro evaluation of coronary stents and in-stent stenosis using a dynamic cardiac phantom and a 64-detector row CT scanner. Clin Res Cardiol. 2007;96:883–90.
34. Gassenmaier T, Petri N, Allmendinger T, et al. Next generation coronary CT angiography: in vitro evaluation of 27 coronary stents. Eur Radiol. 2014;24:2953–61.
35. Rixe J, Achenbach S, Ropers D, et al. Assessment of coronary artery stent restenosis by 64-slice multi-detector computed tomog­raphy. Eur Heart J. 2006;27:2567–72.
36. Ehara M, Kawai M, Surmely JF, et al. Diagnostic accuracy of coro­nary in-stent restenosis using 64-slice computed tomography: com­parison with invasive coronary angiography. J Am Coll Cardiol. 2007;49:951–9.
37. Pugliese F, Weustink AC, Van Mieghem C, et al. Dual source coro­nary computed tomography angiography for detecting in-stent restenosis. Heart. 2008;94(7):848–54.
38. Andreini D, Pontone G, Bartorelli AL, et al. Comparison of feasi­bility and diagnostic accuracy of 64-slice multidetector computed tomographic coronary angiography versus invasive coronary angi­ography versus intravascular ultrasound for evaluation of in-stent restenosis. Am J Cardiol. 2009;103:1349–58.
39. Kubo T, Matsuo Y, Ino Y, et al. Diagnostic accuracy of CT angiog­raphy to assess coronary stent thrombosis as determined by intra­vascular OCT. JACC Cardiovasc Imaging. 2011;4:1040–3.
40. Zhang J, Li M, Lu Z, Hang J, Pan J, Sun L. In vivo evaluation of stent patency by 64-slice multidetector CT coronary angiography: shall we do it or not? Int J Cardiovasc Imaging. 2012;28:651–8.
41. Roura G, Gomez-Lara J, Ferreiro JL, et al. Multislice CT for assess­ing in-stent dimensions after left main coronary artery stenting: a comparison with three dimensional intravascular ultrasound. Heart. 2013;99:1106–12.
42. Sun Z, Almutairi AM. Diagnostic accuracy of 64 multislice CT angiography in the assessment of coronary in-stent restenosis: a meta-analysis. Eur J Radiol. 2010;73:266–73.
43. Rief M, Zimmermann E, Stenzel F, et al. Computed tomography angiography and myocardial computed tomography perfusion in patients with coronary stents: prospective intraindividual compari­son with conventional coronary angiography. J Am Coll Cardiol. 2013;62:1476–85.
44. Onuma Y, Dudek D, Thuesen L, et al. Five-year clinical and func­tional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everoli­mus-eluting scaffold in patients with de novo coronary artery dis­ease: the ABSORB cohort A trial. JACC Cardiovasc Interv. 2013;6:999–1009.
45. Ebersberger U, Tricarico F, Schoepf UJ, et al. CT evaluation of coronary artery stents with iterative image reconstruction: improve­ments in image quality and potential for radiation dose reduction. Eur Radiol. 2013;23:125–32.
46. Eisentopf J, Achenbach S, Ulzheimer S, Layritz C, Wuest W, May M, Lell M, Ropers D, Klinghammer L, Daniel WG, Pfl ederer T. Low-dose dual-source CT angiography with iterative reconstruc­tion for coronary artery stent evaluation. JACC Cardiovasc Imaging. 2013;6:458–65.
47. Oda S, Utsunomiya D, Funama Y, et al. Improved coronary in-stent visualization using a combined high-resolution kernel and a hybrid iterative reconstruction technique at 256-slice cardiac CT-Pilot study. Eur J Radiol. 2013;82:288–95.
48. Zhou Q, Jiang B, Dong F, et al. Computed tomography coronary stent imaging with iterative reconstruction: a trade-off study between medium kernel and sharp kernel. J Comput Assist Tomogr. 2014;38:604–12.
49. Xia Y, Junjie Y, Ying Z, et al. Accuracy of 128-slice dual-source CT using high-pitch spiral mode for the assessment of coronary stents: fi rst in vivo experience. Eur J Radiol. 2013;82:617–22.
10 Coronary CT Angiography After Revascularization
https://t.me/medicina_free
Part III
CT Angiography Assessment for Cardiac Pathology
https://t.me/medicina_free
191
© Springer International Publishing 2016 M.J. Budoff, J.S. Shinbane (eds.), Cardiac CT Imaging: Diagnosis of Cardiovascular Disease, DOI 10.1007/978-3-319-28219-0_11
Assessment of Cardiac Structure and Function by Computed Tomography Angiography
John A. Rumberger
Abstract
High-resolution multi-detector CT (MDCT) scanners capable of quantitative imaging of the heart were introduced around 2002. Initially 16-slice scanners were validated but the cur­rent state of the art is 64+-slice scanners. This chapter discusses the use of 64+-slice MDCT for quantitative assessment of cardiac structure and function.
Keywords
Left ventricle • Systolic function • Diastolic function • MDCT • Cardiac CT
Current State of the Art
CT has traditionally oriented and displayed images parallel or at 90° angles to the long axis of the body (i.e., transaxial, coronal, and sagittal image planes). Such presentations ori­ented about the long axis of the body do not satisfy prior established presentations of cardiac images as they do not cleanly transect the ventricles, atria, or myocardial regions as supplied by the major coronary arteries.
Knowledge of cardiac ejection fractions [ 1 ], absolute ven- tricular volumes [ 2 , 3 ], and location and extent of regional wall motion abnormalities provides valuable diagnostic and prognostic information, and non-invasive cardiac imaging has become the reference standard in routine clinical practice.
The American Heart Association in 2002 [ 4 ] published standards of myocardial segmentation and nomenclature for tomographic imaging of the heart using non-invasive imag­ing modalities and divided the left ventricle (LV) into 17 seg­ments. The nomenclature for image presentation for cardiac CT is: the short axis, horizontal long axis, and vertical long axis, as shown in Fig. 11.1 . These cardiac axes are very familiar to practitioners performing SPECT or PET imaging;
for those familiar with two-dimensional echocardiography, these correspond to the short axis, apical four-chamber, and apical two-chamber views, respectively. These cardiac imag­ing planes are oriented at 90°angles relative to each other [i.e. 3-orthogonal planes].
In order to employ CT to defi ne the cardiac chambers and separate them from the surrounding myocardium, it is necessary to use intravenous contrast. In general, this can be accomplished with <100 mL of non-ionic contrast, and it is possible to perform complete imaging of the heart chambers, the coronary arteries, and the proximal great vessels (aorta and pulmonary artery) in a single setting with a single injection of contrast. Methods for contrast admin­istration for MDCT scanning of the heart are found elsewhere.
Orthogonal (short and various long axes) cardiac CT images after intravenous contrast allow for identifi cation of non-opacifi ed intracardiac thrombi (Fig. 11.2a ) and tumors (Fig. 11.2b ) including excellent resolution of the left atrium and the left atrial appendage (Fig. 11.3 ), allowing localiza- tion of structures smaller than 1 mm [ 5 , 6 ]. Cardiac CT can additionally be of assistance in defi ning thrombi or occult occlusion of the venae cavae and other right-sided structures. Cardiac CT can also be a primary method of defi ning intra­cardiac shunts such as those caused by inter-ventricular (Fig. 11.4a ) and inter-atrial (Fig. 11.4b ) congenital defects and other acquired defects post-infarction [ 7 ].
J. A. Rumberger , PhD, MD Cardiac Imaging , The Princeton Longevity Center , Forestall Village, 136 Main Street , Princeton , NJ 08540 , USA e-mail: jrumberger@theplc.net
1 1
https://t.me/medicina_free
192
Cardiac CT can be used to quantitate left and right ven­tricular volumes [ 810 ], left and right atrial volumes, left and right ventricular muscle mass [ 1114 ], regional left ventricu- lar function, wall thickening and contractility [ 1517 ], rates of diastolic fi lling of the right and left ventricles [ 16 , 18 , 19 ], post-infarction left and right ventricular remodeling [ 2024 ], cardiac remodeling following cardiac [ 25 ] and lung trans- plantation [ 26 ], and ejection fraction [ 2730 ] in patients with no contraindication to the use of iodinated contrast medium. Additional applications include quantitation of uni-valvular regurgitation [ 31 ] and assessment of infarct size [ 32 , 33 ]. The majority of these validation studies was performed in the 1980s and 1990s using EBT and has been adapted and/or re-validated in studies using MDCT. In most instances, these quantitative aspects can be performed or at least well­approximated in patients with generally normal sinus rhythm. Since the number of cardiac cycles imaged per scan is single (256- and 320-slice scanners) or generally limited to <5 (64-slice scanners), quantitation may be limited in those patients with signifi cant dysrhythmias, such as non-regular atrial fi brillation.
All available post-processing workstations can provide quantitative and often non-interactive (i.e., automatic) measurements of the LV in particular. Shown in Fig. 11.5a–e , is the general outline of the procedure and subsequent display
of the results. Table 11.1 shows validated norms for LV chamber size, wall thicknesses, ejection fraction, and ventricular volumes using cardiac CT. Reproducibility of CT in performing right and left ventricular volume and function measurements has also been established [ 34 , 35 ].
Cardiac CT imaging using thin sections allows post­processing of images into end-diastolic and end-systolic short and “long” axis images at multiple ECG-phases to facilitate identifi cation of structures and salient features of the ventricular anatomy (Fig. 11.6 ). Using short and long axis imaging also allows identifi cation of infarct locations (Fig. 11.7 ). Demonstrated in this latter example is a common CT fi nding in contrast-enhanced images from patients with remote myocardial infarction. The “negative” contrast noted in Fig. 11.7 is actually due to lack of contrast opacifi cation in the infarcted region causing “contrast rarefaction.” Long axis (both vertical and horizontal) imaging of the left ventricle also allows for defi nition of basilar and apical infarcts, and true- and pseudo-apical aneurysms (Fig. 11.8 ). Two- dimensional and three-dimensional reconstruction methods, possible in nearly an infi nite number of imaging planes, also allows for postoperative assessment of left ventricular aneurysectomy (Fig. 11.9 ). Global and regional details of the LV due to ischemic cardiomyopathy and hypertrophic cardiomyopathy using cardiac CT provide details commonly
Fig. 11.1 Standardized presentation of the heart in cardiac CT. American Heart Association 17 segment model of the left ventricle (LV); the orthogonal imaging planes are the horizontal long axis, the
vertical long axis, and the short axis (Reprinted from Cerqueira et al. [ 4 ], with permission of Wolters Kluwer Health, Copyright 2002, American Heart Association, Inc.)
J.A. Rumberger
https://t.me/medicina_free